Humana Inc.
NYSE:HUMMedical - Healthcare Plans
+$0.70 today
- Market cap
- $46.32B
- Beta
- 0.77
- P/E (TTM)
- 38.6
- EPS (TTM)
- $9.39
- Dividend yield
- 0.98%
Volume 4.06M
Average 1.72M
HUM Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Humana Inc.NYSE: HUM
Net Margin · Q3 FY2026 · quarter ended Sep 2026
Net margin holds steady near 0.4%
Net margin was 0.4% in Q3 FY2026, down 0.2 pp from a year earlier. On a trailing-twelve-month basis it was 0.8%, down 0.2 pp year over year. Over 3 fiscal years it narrowed by 2.1 pp.
Context
- Net margin widened in 0 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether net margin reaches the consensus estimate from 14 analysts of 0.7% for the fiscal year ending Dec 2026, down from 0.9% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 0.4%-1.3 pp QoQ
- Last fiscal yearDec 2025
- 0.9%-0.1 pp YoY
- LTMSep 2026
- 0.8%-0.2 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -0.2 pp | +0.2 pp | +0.4 pp |
| 1 year | -0.1 pp | -0.2 pp | -0.1 pp |
| 3 years | -2.1 pp | +1.2 pp | +3.3 pp |
| 5 years | +1.2 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 0.9%
- Year-over-year change
- -0.1pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0.9% | -0.1pp |
| FY2024 | 2024-12-31 | 1.0% | -1.3pp |
| FY2023 | 2023-12-31 | 2.3% | -0.7pp |
| FY2022 | 2022-12-31 | 3.0% | -0.5pp |
| FY2021 | 2021-12-31 | 3.5% | — |
Net Margin vs competitors
How HUM compares with its peers on the latest reported figures
- HUM's LTM Sep 2026 net margin of 0.8% is the 6th highest of the 9 companies compared; the peer median is 1.6%.
- Its year-over-year change of -0.2 pp is the 5th highest of 9, against a peer median of -0.2 pp.
- Over three fiscal years its change of -2.1 pp compares with a peer median of -1.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 3.6% | +5.1 pp | +10.9 pp | |
| LTM Sep 2026 | 3.5% | -0.5 pp | -3.5 pp | |
| LTM Sep 2026 | 2.5% | -0.3 pp | -0.9 pp | |
| LTM Sep 2026 | 2.1% | -0.2 pp | -1.5 pp | |
| LTM Jun 2026 | 1.2% | +0.0 pp | -0.9 pp | |
| LTM Sep 2026 | 0.8% | -0.2 pp | -2.1 pp | |
| LTM Mar 2026 | 0.5% | +3.5 pp | +10.4 pp | |
| LTM Sep 2026 | -0.1% | -2.1 pp | -1.4 pp | |
| LTM Jun 2026 | -2.6% | -3.8 pp | -4.3 pp | |
| Peer median (excluding HUM) | 1.6% | -0.2 pp | -1.2 pp | |
Competitors are the stored peer set for HUM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 83.65B | 92.92B | 106.44B | 117.81B | 129.66B |
| Cost of Revenue | 69.2B | 75.69B | 88.39B | 100.66B | 110.81B |
| Gross Profit | 14.45B | 17.23B | 18.05B | 17.15B | 18.85B |
| Gross Margin | 17.3% | 18.5% | 17.0% | 14.6% | 14.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 11.03B | 13.67B | 14.73B | 15.52B | 17.4B |
| Depreciation & Amortization | 713M | 845M | 917M | 968M | 824M |
| EBITDA | 4.46B | 4.81B | 4.73B | 3.26B | 2.91B |
| EBITDA Margin | 5.3% | 5.2% | 4.4% | 2.8% | 2.2% |
| Operating Income | 3.42B | 3.56B | 3.32B | 1.63B | 1.45B |
| Operating Margin | 4.1% | 3.8% | 3.1% | 1.4% | 1.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 326M | 401M | 493M | 660M | 631M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 3.42B | 3.56B | 3.32B | 1.63B | 1.45B |
| Pre-Tax Margin | 4.1% | 3.8% | 3.1% | 1.4% | 1.1% |
| Income Tax Expense | 485M | 762M | 836M | 413M | 250M |
| Net Income | 2.93B | 2.81B | 2.49B | 1.21B | 1.19B |
| Net Margin | 3.5% | 3.0% | 2.3% | 1.0% | 0.9% |
| EPS (Basic) | 22.79 | 22.20 | 20.09 | 10.01 | 9.87 |
| EPS (Diluted) | 22.67 | 22.08 | 20.00 | 9.98 | 9.84 |
| Weighted Avg Shares | 128.69M | 126.42M | 123.87M | 120.57M | 120.45M |
| Weighted Avg Shares (Diluted) | 129.4M | 127.09M | 124.44M | 120.87M | 120.83M |
Humana Inc.
NYSE:HUM
Intrinsic Alpha fair value
Locked
Current Price
$385.71
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.